rxstat › Shortages › Cabergoline
Cabergoline shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Cabergoline products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Jan 1, 2015
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageACT CABERGOLINE
0.5MG · TABLET · ACTAVIS PHARMA COMPANY
DIN 02301407 · since Jan 1, 2015, no end estimate · Requirements related to complying with good manufacturing practices.
ResolvedAPO-CABERGOLINE
0.5MG · TABLET · APOTEX INC
DIN 02455897 · ended Jul 3, 2025 · Disruption of the manufacture of the drug.
ResolvedDOSTINEX
0.5MG · TABLET · PFIZER CANADA ULC
DIN 02242471 · ended Oct 17, 2024 · Demand increase for the drug.
ResolvedAPO-CABERGOLINE
0.5MG · TABLET · APOTEX INC
DIN 02455897 · ended Oct 7, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-CABERGOLINE
0.5MG · TABLET · APOTEX INC
DIN 02455897 · ended Dec 15, 2023 · Disruption of the manufacture of the drug.
ResolvedAPO-CABERGOLINE
0.5MG · TABLET · APOTEX INC
DIN 02455897 · ended Mar 1, 2021 · Disruption of the manufacture of the drug.
ResolvedDOSTINEX
0.5MG · TABLET · PFIZER CANADA ULC
DIN 02242471 · ended Dec 20, 2019 · Demand increase for the drug.
ResolvedDOSTINEX
0.5MG · TABLET · PFIZER CANADA ULC
DIN 02242471 · ended Sep 9, 2019 · Demand increase for the drug.
ResolvedDOSTINEX
0.5MG · TABLET · PFIZER CANADA INC
DIN 02242471 · ended Dec 20, 2018 · Demand increase for the drug.
ResolvedDOSTINEX
0.5MG · TABLET · PFIZER CANADA INC
DIN 02242471 · ended Nov 21, 2018 · Demand increase for the drug.
ResolvedDOSTINEX
0.5MG · TABLET · PFIZER CANADA INC
DIN 02242471 · ended Mar 7, 2018 · Demand increase for the drug.
ResolvedDOSTINEX
0.5MG · TABLET / TABLETTE · PFIZER CANADA INC
DIN 02242471 · ended Apr 27, 2017 · Demand increase for the drug.
What's happening
Cabergoline is currently affected by an active shortage report filed with Health Canada by ACTAVIS PHARMA COMPANY.
The reported cause is: requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Cabergoline is classified under “OTHER GYNECOLOGICALS” (ATC G02CB).
Recent changes
Common questions
When will Cabergoline be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Cabergoline in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All other gynecologicals shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.